Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.

Palucha A, Klak K, Branski P, van der Putten H, Flor PJ, Pilc A.

Psychopharmacology (Berl). 2007 Nov;194(4):555-62. Epub 2007 Jul 12.

PMID:
17622518
2.

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.

Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):1066-74. doi: 10.1124/jpet.110.169730. Epub 2010 Jun 18.

3.

A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats.

Pałucha-Poniewiera A, Pilc A.

Behav Brain Res. 2013 Feb 1;238:109-12. doi: 10.1016/j.bbr.2012.10.004. Epub 2012 Oct 17.

PMID:
23085340
4.

The effects of mGlu₇ receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains.

O'Connor RM, Cryan JF.

Behav Pharmacol. 2013 Apr;24(2):105-13. doi: 10.1097/FBP.0b013e32835efc78.

PMID:
23455446
5.

Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.

Wierońska JM, Stachowicz K, Acher F, Lech T, Pilc A.

Psychopharmacology (Berl). 2012 Apr;220(3):481-94. doi: 10.1007/s00213-011-2502-2. Epub 2011 Sep 28.

6.

Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.

Pałucha-Poniewiera A, Szewczyk B, Pilc A.

Neuropharmacology. 2014 Jul;82:59-68. doi: 10.1016/j.neuropharm.2014.03.001. Epub 2014 Mar 12.

PMID:
24631968
7.

The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.

Bradley SR, Uslaner JM, Flick RB, Lee A, Groover KM, Hutson PH.

Pharmacol Biochem Behav. 2012 Mar;101(1):35-40. doi: 10.1016/j.pbb.2011.11.006. Epub 2011 Nov 25.

PMID:
22138407
8.

A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.

Podkowa K, Rzeźniczek S, Marciniak M, Acher F, Pilc A, Pałucha-Poniewiera A.

Neuropharmacology. 2015 Oct;97:338-45. doi: 10.1016/j.neuropharm.2015.05.039. Epub 2015 Jun 12.

PMID:
26074092
9.

Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.

Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE.

Behav Brain Res. 2009 Mar 2;198(1):83-90. doi: 10.1016/j.bbr.2008.10.018. Epub 2008 Oct 18.

PMID:
18996151
10.

Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.

Greco B, Lopez S, van der Putten H, Flor PJ, Amalric M.

J Pharmacol Exp Ther. 2010 Mar;332(3):1064-71. doi: 10.1124/jpet.109.162115. Epub 2009 Nov 25.

11.

Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission.

Stachowicz K, Brañski P, Kłak K, van der Putten H, Cryan JF, Flor PJ, Andrzej P.

Behav Pharmacol. 2008 Sep;19(5-6):597-603. doi: 10.1097/FBP.0b013e32830cd839.

PMID:
18690114
12.

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.

Pałucha A, Brański P, Szewczyk B, Wierońska JM, Kłak K, Pilc A.

Pharmacol Biochem Behav. 2005 Aug;81(4):901-6.

PMID:
16040106
13.

Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.

Domin H, Jantas D, Śmiałowska M.

Neurochem Int. 2015 Sep;88:110-23. doi: 10.1016/j.neuint.2014.12.010. Epub 2015 Jan 6.

PMID:
25576184
14.

Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.

Summa M, Di Prisco S, Grilli M, Usai C, Marchi M, Pittaluga A.

Neuropharmacology. 2013 Mar;66:215-24. doi: 10.1016/j.neuropharm.2012.04.020. Epub 2012 Apr 27.

PMID:
22564442
15.

Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice.

Boyce-Rustay JM, Holmes A.

Neuropsychopharmacology. 2006 Nov;31(11):2405-14. Epub 2006 Feb 8.

16.

Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.

Li X, Xi ZX, Markou A.

Neuropharmacology. 2013 Mar;66:12-23. doi: 10.1016/j.neuropharm.2012.04.010. Epub 2012 Apr 21. Review.

17.

Additive antidepressant-like effects of fasting with imipramine via modulation of 5-HT2 receptors in the mice.

Li B, Zhao J, Lv J, Tang F, Liu L, Sun Z, Wang L, Siwela SP, Wang Y, Song Y, Manchishi SM, Cui R.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:199-206. doi: 10.1016/j.pnpbp.2013.08.015. Epub 2013 Sep 12.

PMID:
24036107
18.

Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat.

Cavas M, Scesa G, Navarro JF.

Pharmacol Biochem Behav. 2013 Feb;103(4):756-63. doi: 10.1016/j.pbb.2012.12.008. Epub 2012 Dec 21.

PMID:
23262401
19.

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

Pałucha-Poniewiera A, Wierońska JM, Brański P, Stachowicz K, Chaki S, Pilc A.

Psychopharmacology (Berl). 2010 Dec;212(4):523-35. doi: 10.1007/s00213-010-1978-5. Epub 2010 Aug 12.

20.

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY.

Eur Neuropsychopharmacol. 2007 Feb;17(3):172-9. Epub 2006 Apr 21.

PMID:
16630709

Supplemental Content

Support Center